4 Seven additional Phase 3 trials are evaluating retatrutide for obesity without osteoarthritis, type 2 diabetes, obstructive sleep apnea, chronic low back pain, liver disease, and cardiovascular outcomes
Designed to align with the growing momentum of the GLP-1 and appetite regulation markets, the company claims the product demonstrates measurable impacts on hunger perception, food intake and waist circumference, delivering tangible benefits for consumers seeking scientifically validated efficacy
You should not use Mounjaro and Wegovy together
[DOI] [PMC free article] [PubMed] [Google Scholar] 508
Nestlets (Ancare Corp, Bellmore, NY) were provided for physical and mental stimulation